The use of cardiac markers in acute coronary syndromes

References

• American Heart Association. Cardiovascular disease statistics. 1998
   Google Scholar
• World Health Organisation. Report of the Joint International Society and Federation of Clinical Cardiology/WHO Task Force on Standardisation of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979; 59: 607–609
   PubMedGoogle Scholar
• Kannel W B, Abbott R D. Incidence and prognosis of unrecognized myocardial infarction. NEJM 1984; 311: 1144–1147
   PubMed Web of Science ®Google Scholar
• Lee T H, Rouan G W, Weisberg M C, et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. AJC 1987; 60: 219–224
   Google Scholar
• McCullough P A, Ayad O, O'Neill, et al. Costs and outcomes of patients admitted with chest pain and essentially normal electrocardiograms. Clin Cardiol 1998; 21: 22–26
   PubMed Web of Science ®Google Scholar
• Kudenchuk P J, Maynard C, Cobb L A, et al. Utility of prehospizal electrocardiogram in diagnosing acute coronary syndromes: the myocardial infarction triage and intervention (MITI) project. JACC 1998; 32: 17–27
   Google Scholar
• Braunwald E. Unstable angina: a classification. Circ. 1989; 410–414
   PubMedGoogle Scholar
• Karcz A, Korn R, Burke M C, et al. Malpractice claims against emergency physicians in Massachusetts: 1975–1993. Am J Emerg Med 1996; 14: 341–345
   PubMedGoogle Scholar
• Gaspoz J M, Lee T H, Weinstein M C, et al. Costeffectiveness of a new short stay unit to “ruleout” acute myocardial infarction in low risk patients. JACC 1994; 24: 1249–1259
   Google Scholar
• Mair J. Progress in myocardial damage detection: new biochemical markers for clinicians. Crit Rev Clin Lab Sci 1997; 34: 1–66
   PubMed Web of Science ®Google Scholar
• Gerhardt W, Ljungdahl L, Herbert A K. Troponin T and CK-MB(mass) in early diagnosis of ischemic myocardial injury. The Helsingborg Study, 1992. Clin Biochem 1993; 26: 231–240
   PubMed Web of Science ®Google Scholar
• Antmann E, Grudzien C, Mitchell R N, et al. Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T. AHJ 1997; 133: 596–598
   PubMedGoogle Scholar
• Montague C, Kircher T. Myoglobin in the early evaluation of acute chest pain. Am J Clin Path 1995; 104: 472–476
   PubMedGoogle Scholar
• Woo J, Lacbawan F L, Sunheimer R, et al. Is myoglobin useful in the diagnosis of acute myocardial infarction in the emergency department setting?. Am J Clin Path 1995; 103: 725–729
   PubMed Web of Science ®Google Scholar
• Ohman E M, Armstrong P W, Christenson R H, Granger C B, Katus H, Hamm C W, et al. Risk stratification with admission cardiac troponin T concentrations in acute myocardial ischemia. N Engl J Med 1996; 335: 1333–1341
   PubMed Web of Science ®Google Scholar
• Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93: 1651–1657
   PubMed Web of Science ®Google Scholar
• Ravkilde J, Horder M, Gerhardt W, et al. Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction. Scand J Clin Lab Invest 1993; 53: 677–685
   PubMed Web of Science ®Google Scholar
• Mair J, Artner-Dworzak E, Lechleitner P, et al. Cardiac troponin T in diagnosis of myocardial infarction. Clin Chem 1991; 37: 845–852
   PubMed Web of Science ®Google Scholar
• McBride, et al. Assessment of creatinine kinase MB, relative index calculation. troponin T and troponin I in the diagnoses of acute myocardial infarction. Clin Chem 1997; 43: S129, (Suppl)
   PubMedGoogle Scholar
• Wu A HB, Apple F, Gibler B, et al. National Association of Clinical Biochemistry. Guidelines for the use of cardiac markers in coronary artery disease, (in prep)
   Google Scholar
• Wu A HB, Feng Y J, Moore R, et al. Characterisation of cardiac troponin subunit release into serum after acute myocardial infarction and comparision of assays for troponin T and I. Clin Chem 1998; 44: 1198–1208
   PubMed Web of Science ®Google Scholar
• Oltmanns G, Schauer I, Boegel C, et al. Kardiales troponin T bei polytraumatisierten Patienten zur Beurteilung kardialer Komplikationen. Intensivmed Notfallmed 1993; 30: 279
   Google Scholar
• Lee T H, Thomas E J, Ludwig L E, et al. Troponin T as a marker for myocardial ischemia in patients undergoing major non-cardiac surgery. AJC 1996; 77: 1031–1036
   Google Scholar
• Lopez-Jiminez F, Goldman L, Sacks D, et al. Prognostic value of cardiac troponin T after noncardiac surgery: 6-month follow-up data. JACC 1997; 29: 1241–1245
   Google Scholar
• Gornall D A, Roth S N. Serial myoglobin quantitation in the early assessment of myocardial damage: a clinical study. Clin Biochem 1996; 29: 379–384
   PubMed Web of Science ®Google Scholar
• Ricchiuti V, Voss E M, Ney A, et al. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem 1998; 44: 1919–1924
   PubMed Web of Science ®Google Scholar
• Haller C, Zehelein J, Remppis A, et al. Cardiac troponin T in patients with end-stage renal disease: absence of expression in truncal skeletal muscle. Clin Chem 1998; 44: 930–938
   PubMed Web of Science ®Google Scholar
• Kirvan K, Ryan L, Holleman C, et al. Troponin I and troponin T in dialysis treated chronic renal failure - a 1 year follow-up. Clin Chem 1998; 44
   Google Scholar
• Porter G A, Norton T, Bennett W, Troponin B. T, a predictor of death in chronic hemodialysis patients. EHJ 1998; 19: N34–N37, (Suppl. N)
   Google Scholar
• Ooi D S, House A A. Cardiac troponin T in hemodialyzed patients. Clin Chem 1998; 44: 1410–1416
   PubMed Web of Science ®Google Scholar
• Köhrer K, Lang H RM, Ecker M. Experience with cardiac Troponin T in difficult caes. EHJ 1998; 19: N38–N41, (Suppl. N)
   Google Scholar
• Collinson P O. Economic aspects of new biochemical markers for the detection of myocardial damage. Myocardial damage Early detection by biochemical markers, Developments in cardiovascular medicine, J C Kaski, D W Holt. Kluwer Academic Publishers, Dordrecht 1998; Vol 205: 173–187
   Google Scholar
• Hamm C W, Goldmann B U, Heeschen C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. NEJM 1997; 337: 1648–1653
   PubMed Web of Science ®Google Scholar
• Lüscher M S, Ravkilde J, Thygesen K. Clinical application of two novel rapid bedside tests for the detection of cardiac troponin T and creatinine kinase-MB mass/myoglobin in whole blood in acute myocardial infarction. Cardiology 1998; 89: 222–228
   PubMedGoogle Scholar
• Stubbs P, Collinson P, Moseley D, et al. Prospective study of the role of Troponin T in patients admitted with unstable angina. BMJ 1996; 313: 262–264
   PubMed Web of Science ®Google Scholar
• Jurlander B, Molani M A, Balu D, et al. Serum troponin T concentrations predict coronary angiographic findings in patients with unstable angina. Circ. 1995; 92: I-679, (Suppl.)
   Google Scholar
• Stubbs P, Huehns T Y, Collinson P, et al. Angiographic findings in troponin T positive and troponin T negative patients. EHJ 1994; 15: 220, (Suppl.)
   Google Scholar
• Belotti G, Montorfano M, Pizzetti G, et al. Persisitent T wave inversion in Unstable Angina: Its relation to troponin T levels and to culprit lesion severity. Circ. 1995; 92: I-598–599, (Suppl.)
   Google Scholar
• Bertinchant J P, Laperche T, Polge A, et al. Clinical and angiographic findings in troponin I positive and troponin I negative patients admitted with unstable angina. EHJ 1995; 16: 257, (Suppl)
   Google Scholar
• Lindahl, et al. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. JACC 1997; 29: 43–48
   Google Scholar
• The CAPTURE investigators. Randomised placebo-controlled trail of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet 1997; 349: 1429–1435
   PubMed Web of Science ®Google Scholar
• Hamm C W, Heeschen C, Goldmann B U, et al. Value of troponins in predicting therapeutic efficacy of abciximab in patients with unstable angina. JACC 1998; 184A, (Suppl)
   Google Scholar
• Hamm C W, Heeschen C, Simoons M, et al. Troponin T predicts the benefit of abciximab in patients with unstable angina in the CAPTURE study. Abstracts from the European Expert panel Meeting Cardiac Markers, Sorrent, 1998
   Google Scholar
• Ohman E M. Presentation on a satelite symposium of the ESC. Vienna 1998
   Google Scholar
• Stubbs P, Collinson P, Mosely D, et al. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. BMJ 1996; 313: 262–264
   PubMed Web of Science ®Google Scholar
• Rao A C, Collinson P O, Joseph S P, et al. Routine troponin T measurement after myocardial infarction identifies patients who would benefit from long-term teratment with aniotensin converting enzyme inhibitors. EHJ 1996; 17: 265, (Suppl)
   Google Scholar
• Grover A, Rihal C S. The importance of early patency after acute myocardial infarction. Curr Opin Cardiol 1995; 10: 361–366
   PubMedGoogle Scholar
• Ross A M, Lundergan C F, Rohrbeck S C, et al. Rescue angioplasty after failed thrombolysis: technical and clinical outcomes in a large thrombolysis trial (GUSTO-1). JACC 1998; 31: 1511–1517
   Google Scholar
• Mounsey J P, Skinner J S, Hawkins T, et al. Rescue thrombolysis: alteplase as adjuvant treatment after streptokinase in acute myocardial infarction. BHJ 1995; 74: 348–353
   PubMedGoogle Scholar
• Drenth J P, Uppelschoten A, Hooghoudt T E, et al. Rescue thrombolysis may work even though primary thrombolysis has failed. BMJ 1998; 317: 147
   PubMedGoogle Scholar
• Lavin F, Kane M, Forde A, et al. Comparision of five cardiac markers in the detection of reperfusion after thrombolysis in acute myocardial infarction. BHJ 1995; 73: 422–427
   PubMedGoogle Scholar
• Stewart J T, French J K, Theroux P, et al. Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction
   Google Scholar
• Gibson C M, Cannon C P, Greene R M, et al. Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial. AJC 1997; 80: 21–26
   Google Scholar
• Talasz H, Genser N, Mair J, et al. Side branch occlusion during percutaneous transluminal coronary angioplasty. Lancet 1992; 339: 1380–1382
   PubMed Web of Science ®Google Scholar
• Govindaraju V, Manjunath C N, Prabhudev N. Cardiac troponin T is more sensitive in detecting minimal myocardial injury during coronary angioplasty (PTCA). Proceedings of the XVI International Congress of Clinical Chemistry. 1996; 221
   Google Scholar
• Karim M A, Shinn M, Oskarsson H, et al. Significance of cardiac troponin t release after percutaneous transluminal coronary angioplasty. AJC 1995; 76: 521–523
   Google Scholar
• Weber P W, Dill T, Goldmann B, et al. Circulating troponin T and CK-MB mass concentration unmask inapparent myocardial cell injury after successful rotational and balloon coronary angioplasty. EHJ 1993; 14: 246, (Suppl)
   Google Scholar
• Shyu K G, Kuan P L, Cheng J J, et al. Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting. AHJ 1998; 135: 862–867
   PubMedGoogle Scholar
• Rupprecht H J, Terres W, Özbeck C, et al. Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina. JACC, 26: 1637–1642
   Google Scholar
• Bernstein L, Spiekerman A M, Qamar A, et al. Efective resource management using a clinical and laboratory algorithm for chest pain triage. Clin Lan Managment Rev. 1996; 143–152
   Google Scholar
• Heeschen C, Hamm C W, Goldmann B U, et al. Kosteneffektivität eines Troponin-Schnelltests in der Notaufnahme. DMW 1998; 123: 1229–1234
   PubMed Web of Science ®Google Scholar
• Heeschen C, Hamm C W, Goldmann B U, et al. Cost effectiveness of abciximab in patients with unstable angina according to troponin T status. Circ 1998; 98: I-358–I-359, (Suppl)
   Google Scholar
• Fitzmaurice T F, Brown C, Rifai N, et al. False increase cardiac troponin I with heterophilic antibodies. Clin Chem 1998; 44: 2212–2214
   PubMedGoogle Scholar
• Apple F S. Clinical and analytical standardization issues confronting cardiac troponin I. Clin Chem 1999; 45: 18–20
   PubMed Web of Science ®Google Scholar
• Collinson P O. Troponin T or troponin I or CK-MB (or none?). EHJ 1998; 19: N16–N24, (Suppl)
   Google Scholar